MSB 4.69% $1.45 mesoblast limited

Bell Potter valuation, page-131

  1. wot
    10,366 Posts.
    lightbulb Created with Sketch. 1472
    I just don't get it. Surely SI realizes he won't get anywhere without the backing of a big pharma.. They pull all strings - FDA approvals / Govt sway / Market penetration - all this requires the backing of a big pharma, or can be blocked by a big pharma.

    Not sure how or why he thinks last resort debt financing is anything but a short term stop gap.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.